(Q35806246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

A novel agent effective against Clostridium difficile infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

main subject

Clostridium difficile

object named as

Clostridium difficile

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Milka I Yanachkova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Sofya Dvoskin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Wei-Chu Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Neal C Brown

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

George E Wright

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

27 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

19 January 2020

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1624-1626

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

Clostridium difficile DNA polymerase IIIC: basis for activity of antibacterial compounds

19 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

Update on the changing epidemiology of Clostridium difficile-associated disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

Clostridium difficile colitis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

Active site directed inhibitors of replication-specific bacterial DNA polymerases

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294905

Fidaxomicin: Difimicin; Lipiarmycin; OPT 80; OPT-80; PAR 101; PAR-101

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22203600

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clostridium difficile--associated diarrhea

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22203600

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.06097-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22203600%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

22203600

1 reference